2022
DOI: 10.3390/jcm11020295
|View full text |Cite
|
Sign up to set email alerts
|

Exploratory Study on Application of MALDI-TOF-MS to Detect SARS-CoV-2 Infection in Human Saliva

Abstract: SARS-CoV-2 has caused a large outbreak since its emergence in December 2019. COVID-19 diagnosis became a priority so as to isolate and treat infected individuals in order to break the contamination chain. Currently, the reference test for COVID-19 diagnosis is the molecular detection (RT-qPCR) of the virus from nasopharyngeal swab (NPS) samples. Although this sensitive and specific test remains the gold standard, it has several limitations, such as the invasive collection method, the relative high cost and the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(12 citation statements)
references
References 55 publications
0
11
0
Order By: Relevance
“…Reverse‐transcriptase polymerase chain reaction (RT‐PCR) has been the major tool for SARS‐CoV‐2 detection that identifies the viral RNA, primarily because it is minimally invasive and has a rapid turn‐around time (Corman et al, 2020 ; Freire‐Paspuel & Garcia‐Bereguiain, 2021 ; Studdert & Hall, 2020 ). While nasopharyngeal swab is the preferred sample collection method, (Basu et al, 2020 ; Pascarella et al, 2020 ), SARS‐CoV‐2 can also be detected from saliva (Costa et al, 2022 ; Hernandez et al, 2021 ; Takeuchi et al, 2020 ), sputum (Bezstarosti et al, 2021 ), gargle (Chivte et al, 2021 ; Ihling et al, 2020 ; Iles et al, 2020 ), blood (Li, Liu, et al, 2021 ; Peng et al, 2020 ), plasma (Lazari et al, 2021 ), serum (Shen et al, 2020 ; Yan et al, 2021 ), urine (Chavan et al, 2021 ; Peng et al, 2020 ), feces (Li, Liu, et al, 2021 ; Wang, Xu, et al, 2020 ) and breath (Ruszkiewicz et al, 2020 ; Steppert et al, 2021 ) samples. RT‐PCR lacks information on the infectious nature and host–pathogen interactions and cannot distinguish between viable and nonviable virus (Y. Chen et al, 2022 ; Healy et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…Reverse‐transcriptase polymerase chain reaction (RT‐PCR) has been the major tool for SARS‐CoV‐2 detection that identifies the viral RNA, primarily because it is minimally invasive and has a rapid turn‐around time (Corman et al, 2020 ; Freire‐Paspuel & Garcia‐Bereguiain, 2021 ; Studdert & Hall, 2020 ). While nasopharyngeal swab is the preferred sample collection method, (Basu et al, 2020 ; Pascarella et al, 2020 ), SARS‐CoV‐2 can also be detected from saliva (Costa et al, 2022 ; Hernandez et al, 2021 ; Takeuchi et al, 2020 ), sputum (Bezstarosti et al, 2021 ), gargle (Chivte et al, 2021 ; Ihling et al, 2020 ; Iles et al, 2020 ), blood (Li, Liu, et al, 2021 ; Peng et al, 2020 ), plasma (Lazari et al, 2021 ), serum (Shen et al, 2020 ; Yan et al, 2021 ), urine (Chavan et al, 2021 ; Peng et al, 2020 ), feces (Li, Liu, et al, 2021 ; Wang, Xu, et al, 2020 ) and breath (Ruszkiewicz et al, 2020 ; Steppert et al, 2021 ) samples. RT‐PCR lacks information on the infectious nature and host–pathogen interactions and cannot distinguish between viable and nonviable virus (Y. Chen et al, 2022 ; Healy et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…The combination of ML with MALDI-TOF analysis was also tested on clinical saliva samples (105 positive samples and 51 negative samples). Costa et al 163 compared the classification parameters from 5 ML models to the training dataset and found that the SVM with linear kernel (LK) model with 85.2% accuracy, 85.1% sensitivity and 85.3% specificity provided the best results. The authors used an independent dataset for validation, which was measured at 3 time points after sampling: D0, D10 and D30.…”
Section: Ml-host-based Sars-cov-2 Detection Using Maldi-tof Msmentioning
confidence: 99%
“…Particularly due to its discovered advantages over conventional methods, these diagnostic alternatives deserve further development because they could significantly improve the currently available methods. At present, artificial intelligence methods using statistical strategies to recognize statistically significant m / z values (protein/peptide patterns) in positive and negative samples appear to be the most promising approach for SARS-CoV-2 diagnostics by MALDI-TOF MS. 5,17,19,162,163 These strategies do not require the identification of specific biomarkers (corresponding to found m / z values), which simplifies the laboratory work and shortens the analysis time. The obtained m / z values can be identified later, e.g.…”
Section: Future Perspectivesmentioning
confidence: 99%
“…Two main works have addressed this approach, in the first one Nachtigall et al incorporates 211 positive and 151 negative nasal swab samples to their study establishing a diagnostic method with up to 93.9% accuracy, 7% false positives, and 5% false negatives [ 38 ]. In the second one, Costa et al used a non-invasive saliva sampling protocol at different stages (0, 10, and 30 days from the time of inclusion in the study) after patients were diagnosed for COVID-19 [ 39 ]. The best results were obtained at day 0 with an accuracy of 85.2%, sensitivity of 85.1%, and specificity of 85.3%, evaluated in a population of 105 positive and 51 negative patients for SARS-CoV-2 [ 39 ].…”
Section: Mass Spectrometry Approaches For Covid-19 Diagnosismentioning
confidence: 99%
“…In the second one, Costa et al used a non-invasive saliva sampling protocol at different stages (0, 10, and 30 days from the time of inclusion in the study) after patients were diagnosed for COVID-19 [ 39 ]. The best results were obtained at day 0 with an accuracy of 85.2%, sensitivity of 85.1%, and specificity of 85.3%, evaluated in a population of 105 positive and 51 negative patients for SARS-CoV-2 [ 39 ]. The potential application of this alternative approach has the advantage that the sample is applied directly to the MALDI plate for analysis without prior processing, considerably reducing diagnostic times and costs.…”
Section: Mass Spectrometry Approaches For Covid-19 Diagnosismentioning
confidence: 99%